Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1988-07-07
1991-07-02
Moskowitz, Margaret
Drug, bio-affecting and body treating compositions
Lymphokine
530325, 530326, 530350, 514 13, A61K 3900, A61K 3702
Patent
active
050284258
ABSTRACT:
A purified peptide which induces proliferation or activation of cytotoxic T cells specifically against circumsporozoite protein of P. falciparum is described. The peptide has an amino acid sequence KPKDELDYENDIEKKICKMEKCS in single letter amino acid code.
REFERENCES:
patent: 4707357 (1987-11-01), Dame et al.
patent: 4769235 (1988-09-01), Schlesinger et al.
Dame et al., "Structure of the Gene Encoding the Immuno-Dominant Surface Antigen on the Sporozoite of Flu Human Molaria Parasite Plasmodium Falciparum", Science, vol. 225, pp. 593-599, Aug. 1984.
Berzofsky Jay A.
Good Michael F.
Kumar Sanjai
Miller Louis H.
Jain Mishrilal
Mohamed Abdel A.
Moskowitz Margaret
The United States of America as represented by the Department of
LandOfFree
Synthetic vaccine against P. falciparum malaria does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Synthetic vaccine against P. falciparum malaria, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synthetic vaccine against P. falciparum malaria will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1245573